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AIM To assess reliability and predictive validity of the neurological scale of the Standardized
Infant NeuroDevelopmental Assessment (SINDA), a recently developed assessment for
infants aged 6 weeks to 12 months.
METHOD To assess reliability, three assessors independently rated video-recorded
neurological assessments of 24 infants twice. Item difficulty and discrimination were
determined. To evaluate predictive validity, 181 infants (median gestational age 30wks [range
22–41wks]; 92 males, 89 females) attending a non-academic outpatient clinic were assessed
with SINDA’s neurological scale (28 dichotomized items). Atypical neurodevelopmental
outcome at 24 months or older corrected age implied a Bayley Mental Developmental Index
or Psychomotor Developmental Index lower than 70 or a diagnosis of cerebral palsy (CP).
Predictive values were calculated from SINDA (2–12mo corrected age, median 3mo) and
typical versus atypical outcome.
RESULTS Intraclass correlation coefficients of intrarater and interrater agreement of the
neurological score varied between 0.923 and 0.965. Item difficulty and discrimination were
satisfactory. At 24 months or older, 56 children (31%) had an atypical outcome (29 had CP).
Atypical neurological scores (below 25th centile, ≤21) predicted atypical outcome and CP with
sensitivities of 89% and 100%, and specificities of 94% and 81% respectively.
INTERPRETATION SINDA’s neurological scale is reliable and in a non-academic outpatient
setting has a satisfactory predictive validity for atypical developmental outcome, including
CP, at 24 months or older.
During infancy the identification of children at high risk of
developmental disorders, such as cerebral palsy (CP), intel-
lectual disability, and autism spectrum disorder, is improv-
ing.1–3 In particular, in infants who spend the beginning of
extrauterine life in the neonatal intensive care unit, the
combination of neonatal neuroimaging in combination
with the assessment of general movements results in highly
accurate prediction of CP.3,4 Much less is known about the
prediction of developmental disorders in the general popu-
lation where a priori risk of these disorders is low; yet it is
from this population that most children with a develop-
mental disorder originates. Early detection in general pae-
diatrics occurs only partially in the age period with general
movements, that is before 5 months corrected age; most
early detection in this setting takes place during the first
12 months postterm.1,2 Most paediatricians do not apply a
standardized method, but use an eclectic sample of neuro-
logical and developmental test items.
A clinical tool often used in prediction is neurological
examination. Various standardized variants exist, such as
the Hammersmith Infant Neurological Examination
(HINE),5,6 the Touwen Infant Neurological Examination,7
and the examination according to Amiel-Tison and Gre-
nier.8 From the methods mentioned, the HINE is the
quickest to perform.6 According to the scientific literature,
the HINE is also the most frequently used method inter-
nationally. Whether the existing neurological exams also
accurately predict atypical outcomes other than CP, or CP
in the general population, has not been investigated.
A systematic review on infant neuromotor assessments
confirmed that the neurological examinations mentioned
above serve the prediction of CP relatively well, but not
as well as the assessments that include the quality of
spontaneous motor behaviour.1 This is especially true if
the quality of spontaneous motor behaviour is assessed in
terms of variation versus stereotypy.1,6,9 As the existing
neurological exams pay relatively little attention to the
quality of spontaneous movements, we (MH-A, UT, JP,
and HP) embarked on the development of a new neu-
rodevelopmental assessment tool, the Standardized Infant
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NeuroDevelopmental Assessment (SINDA), that would
include a substantial number of items evaluating this
aspect of neurological behaviour. SINDA aims to be a
screening tool for infants aged 6 weeks to 12 months,
which is easy to learn and apply in a standardized way,
and aims to allow general paediatricians to detect infants
at high risk of developmental disorders, that is CP and
other developmental disorders. SINDA has three scales: a
neurological scale (28 items, with a special focus on the
quality of spontaneous motility), a standardized develop-
mental scale (16 items for each month, covering cognitive,
language, gross and fine motor development; 122 items in
total) and a social-emotional scale (6 items evaluating inter-
action, emotionality, self-regulation, and reactivity). The
current paper addresses only the neurological scale; it was
the scale developed first. The developmental and socio-
emotional scales were introduced into routine clinical work
in 2013. We will report their results in the near future.
SINDA’s neurological scale
SINDA’s neurological scale has been designed as a screen-
ing tool that: (1) is applicable in the first year of life after
the neonatal period, that is in the age range of 6 weeks to
12 months corrected age; (2) covers all infant neurological
domains; (3) is standardized, that is it has an identical set
of items and criteria in the age range at issue; (4) results in
a score that is largely independent of the infant’s age; (5) is
easy for general paediatricians to use and takes about 10
minutes to perform (including recording of the scores); (6)
includes a substantial proportion of items evaluating the
quality of spontaneous movements; and (7) assists the pre-
diction of developmental outcome.
The neurological scale has five domains assessing spon-
taneous movements (eight items), cranial nerve function
(seven items), motor reactions (five items), muscle tone
(four items), and reflexes (four items; see Appendix S1,
online supporting information). The assessment proce-
dures, definition of the items, and criteria for typical and
atypical performance have been described in the manual
(hitherto unpublished).
Each item is scored as pass or fail according to simple
and well-defined criteria. For many items, consistent asym-
metry results in the assignment of ‘fail’. Seven of the eight
items on spontaneous motility evaluate movement quality
in terms of variation versus stereotypy, the eighth item
addressing the quantity of motility. The classification of
movement variation versus stereotypy is based on clinical
observation, not on video assessment as in the assessment
of general movements.1 This implies that only striking
stereotypies, including consistent asymmetries, are
recorded as atypical, in line with clinical practices.7,10–12
The inclusion of seven items on movement quality also
means that asymmetries, such as a head-turn preference
with an accompanying asymmetry in arm movements, and
eventually in hand movements which occurs relatively fre-
quently in 2-month or 3-month-old infants, only results in
a reduction of 2 or 3 points. The latter may be interpreted
as a minor dysfunction. This contrasts with strikingly
stereotyped movements in all parts of the body that will
result in a 7-point reduction of the score. The cranial
nerve function domain includes items assessing facial and
oral motor behaviour, eye movements, and reactions to
light and sound. The motor reactions domain consists of
items evaluating the infant’s reaction to postural stimula-
tion; examples are the pull-to-sit manoeuvre and vertical
suspension. Muscle tone is evaluated separately in neck and
trunk, arms, legs, and feet. The reflexes domain does not
only contain tendon reflexes, but also the footsole response
and footsole sensibility (i.e. the response of the infant’s
foot to gentle tickling). We decided to exclude responses
such as the Moro response, the palmar and plantar grasp
responses, and the parachute reaction from the examina-
tion as they are clearly age-dependent. The latter inter-
fered with our aim to develop an assessment that was
largely independent of the infant’s age in the first postterm
year.
The aim of the present study was to assess the follow-
ing properties of SINDA’s neurological scale in a sample
of infants at risk of motor and mental developmental dis-
orders: (1) intrarater and interrater reliability; (2) item
difficulty and item discrimination; (3) dependency on
infant age; and (4) validity to predict adverse developmen-
tal outcome at 24 months or older corrected age. This
means that the present study is a first phase in the valida-
tion of SINDA’s neurological scale. One of our next steps




The study is a centre-based longitudinal case series, con-
sisting of 181 infants (92 males, 89 females) who had been
admitted to the Centre for Child Neurology in Frankfurt,
Germany (SPZ Frankfurt-Mitte). Social paediatric centres
in Germany are specialized outpatient clinics for infants at
risk of or with a neurodevelopmental disorder. From May
2012, SINDA’s neurological scale was incorporated in SPZ
Frankfurt-Mitte’s clinical routine. In the present study
infants were consecutively included when they had their
first visit when aged between 6 weeks and 12 months
between May 2012 and November 2014, and had detailed
outcome data reported in the medical records at
24 months or older corrected age. The latter included a
neurological examination and a standardized neurodevelop-
mental assessment in 177 (98%) infants. Infants were
excluded if they had (1) a progressive neurological disorder
(n=4); (2) a behavioural state incompatible with SINDA
(n=1); or (3) a phenotypical expression of a genetically
What this paper adds
• The Standardized Infant NeuroDevelopmental Assessment’s neurological
scale has a good to excellent reliability.
• The scale has promising predictive validity for cerebral palsy.
• The scale has promising predictive validity for other types of atypical devel-
opmental outcome.
2 Developmental Medicine & Child Neurology 2018
determined developmental disorder as this may cause asses-
sor bias (n=13, all trisomy 21). Also excluded were the
infants who had a SINDA, but no follow-up assessment at
24 months or older. The latter was mostly because of their
clinical status requiring no or less specialized follow-up.
Table I summarizes the background characteristics of the
study group. The study was approved by the ethical com-
mittee of the Medical Faculty of Heidelberg University,
Germany (S-021/2017).
SINDA
SINDAs were performed by the seven general paediatri-
cians (of whom three were in training for paediatric neu-
rology) of SPZ Frankfurt-Mitte. These paediatricians had
received the SINDA manual (unpublished material) and
been trained in using SINDA through video sessions and
attending life assessments performed by one of SINDA’s
developers (HP). SINDA’s neurological scale has been
described in the introduction (see also Appendix S1). Each
of the 28 items is scored as pass (1) or fail (0). The number
of passed items is added to form SINDA’s neurological
score, with a maximum of 28 points and the various
domain scores.
Neurodevelopmental assessment at 24 months or older
At a median age of 29 months corrected age (range 24–
57mo), the children had a follow-up assessment by the
clinical team of SPZ Frankfurt-Mitte (consisting of seven
paediatricians and two psychologists). The paediatrician in
charge of the follow-up assessment knew the medical his-
tory of the child and the child’s SINDA scores. However,
the paediatrician was not aware of the significance of the
SINDA scores, as that was undetermined at that time. The
follow-up assessment consisted of a neurological and physi-
cal examination by one of the paediatricians, and a stan-
dardized developmental assessment by one of the
psychologists. The neurological examination was the stan-
dardized assessment described by Michaelis and Ber-
ger.11,12 The diagnosis of CP was based on this
assessment, according to the criteria of the Surveillance of
Cerebral Palsy in Europe.13 In children aged less than
43 months, the developmental assessment consisted of the
Bayley Scales of Infant Development, Second Edition mea-
sure;14 in three older children other standardized tests were
used for mental development (Snijders-Oomen Non-Ver-
bal Intelligence Test revised version,15 Wechsler Preschool
and Primary Scale of Intelligence,16 and the ET 6–6 devel-
opmental assessment),17 and in two children for motor
development (Movement Assessment Battery for Children,
Second Edition18 and ET 6–6). In another four children,
whose neurological exam showed typical function, develop-
mental outcome was based on developmental screening by
the paediatrician. This screening showed average or above
average performance. At the time of our study, the Ger-
man norms of the Bayley Scales of Infant Development,
Third Edition were not available and application of the
US-norms had some problems; therefore the Bayley Scales
of Infant Development, Second Edition was used.19 The
Bayley Scales of Infant Development, Second Edition
results in two outcome scores, the Psychomotor Develop-
ment Index and the Mental Development Index. Outcome
was classified as typical or atypical, with atypical outcome
implying the presence of a clear neurological syndrome
such as CP or the presence of a Mental Development
Index and/or Psychomotor Development Index lower than
70 or its equivalent.
Evaluation of psychometric properties and statistical
analyses
Interrater and intrarater reliability was calculated on the
basis of 24 videotaped SINDA neurological examinations;
this number is in line with similar studies in the field.5
The videos were selected by the clinical staff, who were
not involved in the reliability study. Care was taken to cre-
ate a sample that included variation in age and neurologi-
cal dysfunction (for details see Table SI, online supporting
information). Three assessors (MH-A, JP, and HP),
Table I: Characteristics of the study sample (n=181)
Sex (M/F) 92/89
Age at SINDA assessment in




High, middle, low, n (%) 73 (46%), 59 (37%), 27 (17%)
Paternal education,a n=158
High, middle, low, n (%) 77 (49%), 52 (33%), 29 (18%)










Artificial ventilation, n (%) 60 (35%)
BPD, n (%) 22 (13%)
Brain lesions,c n (%)
IVH grade 3–4 8 (4%)
PVL 4 (2%)
Asymmetric ventricular system 3 (2%)
Otherd 8 (4%)
Developmental outcome ≥24mo
CP n (%) 29 (16%)
Bilateral spastic CP 19 (10%)
Unilateral spastic CP 8 (4%)
Dyskinetic CP 2 (1%)
Distribution
GMFCS level I, II, III, IV, V (n)
7, 5, 3, 9, 5
Developmental delay (PDI/MDI <70) 53 (29%)
aParental education: high=university or vocational college; mid-
dle=low or middle level of vocational education; low=not exceeding
elementary school. bSmall for gestational age=birthweight <10th
centile. cImaging (ultrasound, magnetic resonance imaging) was
performed on clinical indication or as part of routine in the neona-
tal intensive care unit in n=173. dExamples of other brain lesions
are pachygyria, cortical atrophy, subdural bleeding, and hydro-
cephalus. BPD, bronchopulmonary dysplasia; CP, cerebral palsy;
GMFCS, Gross Motor Function Classification System; IVH,
intraventricular haemorrhage; MDI, Mental Developmental Index;
PDI, Psychomotor Developmental Index; PVL, periventricular
leukomalacia; SINDA, Standardized Infant NeuroDevelopmental
Assessment.
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masked to the infant’s age and clinical history, indepen-
dently assessed the videos twice with an interval of 14 to
18 months. The intrarater agreement was based on the
two assessments of the three examiners. To determine the
interrater agreement, the second assessment of the three
examiners was used. The video-assessments did not allow
for the evaluation of the item ‘pupillary reaction’. Of the
remaining 648 items (27 items for 24 infants) another 21
single item-assessments (3.2%) had to be excluded because
of impaired visibility on the video. Thus a final set of 627
videotaped items of 24 neurological assessments was used
for intrarater and interrater reliability.
Reliability was calculated using two approaches.20 First,
Cohen’s kappa coefficient K, a robust measure for rater
agreement, was used to determine intrarater and interrater
reliability for the categorical single items (only possible for
two raters).21 According to Fleiss,22 kappa values of 0.40 to
0.75 are rated as fair to good. Second, intraclass correla-
tion coefficients (ICC 2,k) were calculated to evaluate
intrarater and interrater reliability of domain scores and
the total score. ICC calculation is a proper inferential sta-
tistical method for quantitative measurements; ICCs can
be derived for multiple raters.23
Special attention was paid to item analysis, an important
issue in the development of tests. It refers to statistical
methods used to select valuable items for inclusion in the
test under construction. We calculated two parameters:
item difficulty and item discrimination. Evaluation of these
parameters was based on all 181 SINDA assessments avail-
able. To calculate item difficulty for dichotomous items –
as in SINDA – the number of positive items (in our case
atypical performance) is divided by the number of exami-
nees; this results in a proportion, on the scale of 0 to 1.
Item discrimination was based on a point-biserial correla-
tion of the single items (0=atypical, 1=typical) with the
total score. The item discrimination provides an estimate
of the degree to which a particular item is measuring the
same aspects as the test as a whole. Its value can range
between 0 and 1, with 1 indicating a perfect discrimina-
tion.
To assess whether SINDA’s neurological scale was lar-
gely independent of age, the association between the
infant’s corrected age at assessment and the neurological
(total) score was evaluated with the Spearman rank correla-
tion coefficient (rho [q]).
Predictive validity of the SINDA assessment was calcu-
lated for two different outcomes (atypical outcome and
CP). We determined a score below the 25th centile of the
study group as ‘at risk’, a cut-off also meeting face validity
(Fig. 1). Next, sensitivity and specificity of the at risk score
for atypical neurodevelopmental outcome or CP at follow-
up was determined, including their 95% confidence inter-
vals (CI).
Most statistical analyses were performed on a personal
computer system using SAS Version 9.4 (SAS Institute,
Cary, NC, USA). ICC calculations were performed using
the statistical package R version 3.4.2 (R Foundation for
Statistical Computing, Vienna, Austria). We used paramet-
ric and non-parametric statistics when applicable. For
instance, age at examination and neurological total score
did not meet the criteria of normal distribution, we there-
fore used median and centile values as descriptors, and we




The duration of the video recordings of the neurological
assessments varied between 4 minutes 45 seconds and
10 minutes 52 seconds (median: 8min 20s). For the sin-
gle items, the Cohen kappa values of intrarater agree-
ment were 0.601 (HP), 0.644 (MH-A), and 0.718 (JP),
denoting substantial agreement. The ICCs of the intrara-
ter agreement of the total scores varied between 0.923
and 0.947, indicating excellent agreement; the ICCs of
the domain scores reflected good to excellent agreement
(Table II).
For the single items, the Cohen kappa values of inter-
rater agreement were 0.572, 0.672, and 0.667, again
implying substantial agreement. For the domain scores,
all but one of the ICCs of the interrater agreement were
higher than 0.750, the single value of the reflexes domain
(0.573) being the exception to the rule (Table II). The
ICCs of the interrater agreement of the total scores indi-
cated excellent agreement, with an overall ICC (2,k) of
0.965.
Item difficulty, item discrimination, and age-dependency
The easiest item was ‘pupillary reaction’ (item 14, cranial
nerve function) which was scored atypical by one infant
only (0.6%); the most difficult item was ‘pull-to-sit’ (item
16, motor reactions) which was scored atypical in 71
infants (39%). Mean item difficulty was 20% (Figure S1,
online supporting information).
The point-biserial correlation analysis indicated that the
mean discrimination index was 0.477, indicating adequate
discrimination. The correlation coefficients ranged from
0.107 (‘pupillary reaction’, item 14, cranial nerve function)
to 0.702 (‘spontaneous movements of the hands’, item 3,
spontaneous movements; ‘resistance against passive move-
ments of the arms/arm traction’, item 22, muscle tone); see
Figure S1, online supporting information.
Item difficulty and item discrimination revealed, for
instance, that the item ‘pull-to-sit’ (item 16, motor reac-
tions) is an item on which infants frequently ‘failed’ (atypi-
cal in 39%). Its item discrimination of 0.366 indicated that
the contribution of this item to the test result as whole is
only moderate. The item difficulty and item discrimination
also indicated that the item ‘pupillary reaction’ is an item
on which infants infrequently scored atypical, and that its
contribution to the overall risk score was limited (item dif-
ficulty 0.107). Nevertheless, we considered the item neuro-
logically too important to be left out of SINDA’s
neurological scale.
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The infant’s corrected age at assessment was not associ-
ated with the neurological score (q=–0.019; p=0.803).
Predictive validity
The SINDA neurological (total) scores ranged from 7 to
the maximum of 28. Preliminary analysis indicated that the
lowest 25th centile meant a score of 21 points or lower.
Therefore, we calculated the sensitivity and specificity of a
SINDA neurological score of 21 points or lower. This cut-
off for at risk was first used to calculate sensitivity and
specificity for atypical neurodevelopmental outcome at 24
months or older, which was diagnosed in 56 children: sen-
sitivity was 0.893 (95% CI 0.781–0.960) and specificity was
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Figure 1: Neurological scores and neurodevelopmental outcome. The figure depicts the number of infants with a typical and an atypical neurodevelop-
mental outcome (≥24mo) per neurological score on their Standardized Infant NeuroDevelopmental Assessment.
Table II: Intrarater and interrater reliability of total and domain scores (ICC scores)
SM CN MR TO RE Total score
Intrarater agreement
MH-A 0.868 0.925 0.831 0.931 0.823 0.941
<0.001 <0.001 <0.001 <0.001 0.001 <0.001
HP 0.875 0.804 0.864 0.880 0.859 0.923
<0.001 0.001 <0.001 <0.001 <0.001 <0.001
JP 0.947 0.820 0.906 0.909 0.866 0.947
<0.001 <0.0001 <0.001 <0.001 <0.001 <0.001
Interrater agreement
MH-A, HP 0.924 0.854 0.836 0.867 0.573 0.925
<0.001 <0.001 0.001 <0.001 0.024 <0.001
MH-A, JP 0.908 0.971 0.909 0.917 0.785 0.956
<0.001 <0.001 <0.001 <0.001 0.001 <0.001
HP, JP 0.911 0.886 0.896 0.947 0.815 0.961
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001
HP, JP, MH-A 0.941 0.935 0.919 0.939 0.807 0.965
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001
The upper values denote the intraclass correlation coefficients (ICCs), the lower values are the corresponding p-values. ICC values were
interpreted as: <0.40: poor; 0.40–0.59: fair; 0.60–0.74: good; 0.75–1.00: excellent.25 CN, cranial nerve function (seven items); MHA, HP, and
JP, the three assessors; MR, motor reactions (five items); RE, reflexes (four items); SM, spontaneous movements (eight items); TO, muscle
tone (four items).
Table III: Association between SINDA neurological scores and atypical








no CP All atypical
>21 117 0 6 6 123
≤21 8 29 21 50 58
Total 125 29 27 56 181
Atypical vs typical outcome (n=181): v2 (df 1)=122.0, p<0.001; CP vs
no CP (n=181): v2 (df 1)=73.2, p<0.001; in children without CP
(n=152): atypical vs typical outcome: v2 (df 1)=73.3, p<0.001. CP,
cerebral palsy; SINDA, Standardized Infant NeuroDevelopmental
Assessment.
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Twenty-nine children were diagnosed with CP (Table I).
The sensitivity to predict CP was 1.000 (95% CI 0.881–1.000)
and its specificity was 0.809 (95% CI 0.738–0.868; Table III).
Twenty-seven children had an atypical outcome but not CP,
most often consisting of a low Mental Development Index.
The sensitivity to predict atypical outcome in the group of chil-
dren without CP was 0.778 (95%CI 0.577–0.914) and speci-
ficity was 0.936 (95% CI 0.878–0.972; Table III).
DISCUSSION
The present study indicated that the SINDA neurological
scale had a satisfactory intrarater and interrater reliability
with good to excellent levels of agreement. In addition, the
scale had an adequate item difficulty and item discrimina-
tion, its score was largely independent of age, and had a
promising power to predict atypical developmental out-
come at 24 months or older corrected age.
Our aim was to construct a standardized neurological
scale that was largely independent of the infant’s age,
that is, a scale in which an identical set of items and
criteria, and an identical cut-off for at risk was applicable
at all test ages. Because of the rapid developmental
changes in the young brain24 this was a challenge, even
though we set the upper age limit of SINDA at
12 months corrected age. Yet the current data showed
that we were successful. This independency of age is a
unique characteristic of SINDA, as the other infant neu-
rological assessments use age-specific criteria for cut-off
of typical behaviour and/or age-specific criteria to classify
atypical performance.6–8
SINDA neurological scores in the lowest 25th centile
(i.e. scores of ≤21 points) predicted atypical developmen-
tal outcome well. This cut-off resulted in sensitivities of
89% and 100%, and specificities of 94% and 81% for
atypical development and CP respectively. The sensitivity
values indicated that SINDA’s neurological scale, which
aims to screen for high risk of developmental disorders,
did not miss any infant later diagnosed with CP and
only 6 of the 56 (11%) children with atypical outcome
at 24 months or older corrected age. The predictive val-
ues for CP are comparable to those reported for the
prediction of CP with HINE assessments in the first
year (sensitivity 90%–96%, specificity 85%–100%).6 The
HINE studies only reported predictive values for CP,
not for atypical outcome in general. The satisfactory
predictive values of SINDA’s neurological scale for atypi-
cal outcome in children without CP indicate that the
scale is not only a useful screener for the detection of
high risk of CP, but also for the detection of high risk
of other developmental disorders. The inclusion of a
substantial number of items evaluating the quality of
spontaneous movements in terms of variation and stereo-
typy may have contributed to this prediction, as increas-
ing evidence suggests that stereotyped movements in
infancy is not only associated with CP but also with
other developmental disorders, such as impaired cogni-
tion25,26 and autism spectrum disorder.27 In the
calculation of predictive values we applied a cut-off score
for ‘at risk’. This, however, obscured the notion of bor-
derline scores. Future studies need to address the value
of these scores.
We aimed at an assessment that lasted 10 minutes. The
video recordings indicated that this goal was achieved,
despite the inclusion of the observation of spontaneous
movements which takes at least 3 minutes. We consider a
duration of 10 minutes acceptable, particularly in view of
the satisfactory prediction of SINDA’s neurological scale
of atypical outcome.
The strengths of this study are the development of a
neurological screening instrument with identical items and
criteria that is applicable in the first year of life. Another
strength is that we tested the predictive validity of SIN-
DA’s neurological scale in a non-academic setting, that is,
in a typical German social paediatric centre setting. The
setting was, however, not that of the general paediatricians
for whom SINDA is designed, but a specialized outpatient
clinic for infants at risk of or with neurodevelopmental dis-
orders. This means that future research needs to address
the reliability and predictive validity of SINDA’s neurolog-
ical scale in a general paediatric setting. The specific set-
ting of the current study was also associated with some
limitations. First, follow-up was carried out in clinical rou-
tines, inducing some variation in age at assessment (but in
all: ≥24mo) and – associated to the age-variation – some
variation in assessments. Second, the clinical setting meant
that the paediatricians in charge of the follow-up examina-
tions knew the infant’s SINDA score (i.e. they had a clini-
cal bias). Third, the setting also implied that a relatively
large proportion (31%) of the infants had an atypical out-
come. This group composition increases the a priori
chance of getting satisfactory predictive values and implies
that our data should be interpreted with caution. On the
other hand, it should be realized that the predictive validity
of novel developmental tests is virtually always tested in
groups with a comparable composition.28–30 Our reliability
assessment by means of video recordings may be consid-
ered another weakness of the study, as life reassessment of
the infant at a short interval is theoretically better. How-
ever, the advantage of video assessment is a lower assess-
ment burden for the infant, who needs to be assessed only
once.
In conclusion, our study indicated that SINDA’s neuro-
logical scale can be reliably administered in about 10 min-
utes and – in a specialized non-academic outpatient setting
– may be associated with a satisfactory predictive validity
for atypical developmental outcome, including CP, at
24 months or older.
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